Friday, April 17, 2026

1:00-4:00 PM PT
PDS01 - Grant Writing Workshop: Tips for Success from Experienced Scientists
DCP Co-Chair: Luz Maria Rodriguez, M.D.

3:00-4:30 PM PT
ED54 - Decoding Tumor Evolution through the Human Tumor Atlas Network: An Ecological and Evolutionary Perspective
NCI Presenter: Indu Kohaar, Ph.D.

Sunday, April 19, 2026

Poster Section 37
Session PO PRO2.01 Experimental Chemoprevention and Interceptions: Data and Tools

2:00-5:00 PM PT
942/1 – Target validation and high-throughput screening assay development for natural product discovery for cancer prevention and interception
NCI Presenters:  Robert H. Shoemaker, Ph.D., Altaf Mohammed, Ph.D., Kajal Biswas, Ph.D.

944/3 – The combination of EPA and naproxen prevents iCAF polarization and attenuates inflammation associated with PIRcTumor development
NCI Presenters: Shizuko Sei, M.D., Vignesh Gunasekharan, Ph.D.

948 / 7 – TRAIL inducing drug, ONC201 prevents adenocarcinoma in transgenic KRASG12V mouse lung cancer model
NCI Presenters: Shizuko Sei, M.D., Vignesh Gunasekharan, Ph.D.

950 / 9 – Efficacy of androgen receptor inhibitor, Apalutamide, in intercepting bladder cancer in a BBN-induced rat bladder tumor model
NCI Presenters: Shizuko Sei, M.D., John Clifford, Ph.D.

951 / 10 – STAT3 inhibitor TTI-101 effectively intercepts bladder cancer in a carcinogen-induced rat bladder tumor model
NCI Presenters: Shizuko Sei, M.D., Vignesh Gunasekharan, Ph.D.

963 / 22 – Preclinical testing of A2B adenosine receptor inhibitor PSB1115 for pancreatic cancer immunoprevention
NCI Presenters: Shizuko Sei, M.D., John Clifford, Ph.D.

NCI Meet the Experts: Human Tumor Atlas Network (HTAN) Resources at the NCI Exhibit (Booth #736)

4:00-4:30 PM PT
DCP Expert: Indu Kohaar, Ph.D.; DCB Experts Sean Hanlon, Ph.D., Sharmi Ghosh-Janjigian, Ph.D.

Monday, April 20, 2026

Meet the Experts: Liver and Pancreatic Cancer Early Detection Research Programs at NCI at the NCI Exhibit (Booth #736)

11:00-11:30 AM PT
DCP Expert: Sidney Fu, M.D. 

Room 1 – Upper Level – Convention Center

12:30-2:00 PM PT
Session DC 12 – Cancer Prevention and Screening: Exploring Policy Solutions 
NCI Panelist: Philip E. Castle, Ph.D. M.P.H.

Poster Section 38
Session PO.CH01.05 - Natural Products

2:00-5:00 PM PT
3653 / 12 – Screening of natural products library against 5-lipoxygenase (5-LOX) and mPGES1 proinflammatory targets for CRC interception
NCI Presenters:  Kajal Biswas, Ph.D., Altaf Mohammed, Ph.D., Robert H. Shoemaker, Ph.D.

Meet the Experts: DCP Natural Products Program at the NCI Exhibit (Booth #736)

3:00-3:30 PM PT
DCP Experts: Altaf Mohammed, Ph.D., and Kajal Biswas, Ph.D. 

Tuesday, April 21, 2026

Room 2 – Upper Level Convention Center

Session NIH07 - NCI/NIH Consortia Initiative

10:15-11:15 AM PT 
Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancers
NCI Presenters: Edward Sauter, M.D., Ph.D., Anil Wali, Ph.D., Wanping Xu, Ph.D.